USC Roski Eye Institute- Refractive Surgery Center

History

Established in 1975. The USC Roski Eye Institute is widely recognized as a trailblazer in patient care, vision research and physician education. The U.S. News & World Report has ranked USC Ophthalmology among the top 10 ophthalmology programs in the country for 21 years. The institute is known for PROSE therapy (used to treat cornea disorders), advanced clinical trials, the latest surgical techniques and its partnership with Children's Hospital Los Angeles for pediatric and developmental eye care. * USC Roski Eye Institute is ranked in the top 10 for research funding by the National Eye Institute * USC Roski Eye Institute is ranked among the nation's top 10 Ophthalmology programs by both U.S. News & World Report * Mark Humayun, MD, PhD, led a team that developed the FDA-approved Argus II that restores some visual capabilities for certain blind patients.

Specialties

At the USC Roski Eye Institute, we pride ourselves on providing our patients with cutting-edge diagnostic and treatment options in order to optimize visual outcomes and minimize surgical risks and complications. Because of our commitment to high quality eye care, the USC Roski Eye Institute has been a consecutive top ranked program nationally.